The search found 3759 results.
Blog
Introducing Electronic Prescribing of Controlled Substances is a great business move for pharmacists - read a pharmacist's arguments for EPCS adoption
Press
Lexington, Mass.—October 20, 2014—Imprivata® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that the company will release the results for its third quarter ended September 30, 2014 after the market closes on Monday, November 3, 2014. Imprivata will hold a conference call for investors on November 3 at 5:00 p.m. EDT during which management will review highlights from the company's third quarter 2014 results, its business outlook and other matters.
Blog
A leading Customer Experience expert in the Healthcare IT industry shares her strategy for developing a truly unique & empowering customer experience
Press
Steven Zuber, MD, CMIO of Methodist Health System, to Outline DEA Requirements for e-Prescribing of Controlled Substances, the Benefits to Clinical Staff and Steps for EPCS Success
Press
Lexington, Mass. — October 31, 2014—Imprivata® (NYSE: IMPR) today announced that members of management will participate in two upcoming investor conferences.
Omar Hussain, President and CEO, and Jeff Kalowski, Chief Financial Officer, will present at the Stephens Fall Investment Conference in New York, New York on Tuesday, November 11, 2014 at 1:00 PM ET.
Mr. Hussain and Mr. Kalowski will also present at the Piper Jaffray Healthcare Conference in New York, New York on Wednesday, December 3, 2014 at 9:00 AM ET.
Datasheet
Imprivata Enterprise Access Management self-service password reset provides clinicians with a fast, easy and secure method to reset and retrieve passwords. Security and compliance requirements mandate that passwords be complex and difficult to guess, so they are often forgotten. This leads to calls to the helpdesk, which frustrates providers, impedes the patient care process and adds cost for IT.
Press
Imprivata achieves record revenues of $25.3 million, a 41% increase over the comparable period of 2013, and increases annual revenue guidance.
Blog
Make a well-informed decision about which two-factor authentication modalities to introduce to your EPCS process: keep prescriber satisfaction in mind